Serum Neurofilament Light Chain and Cardiovascular Outcomes in Patients With Atrial Fibrillation

Atrial Fibrillation

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Heart Rhythm

Boriani G, McIntyre WF, Ramasundarahettige C, Proietti M, Glotzer TV, Diemberger I, Nielsen JC, Essebag V, Granger CB, Sandhu RK, Benezet-Mazuecos J, Mabo P, Coutu B, Wong JA, Gold MR, Lopes RD, Healey JS, ARTESiA Investigators

doi: 10.1016/j.hrthm.2025.07.002

Atrial Fibrillation

Integrated Care Management for Older Multimorbid Patients with Atrial Fibrillation: Rationale, Design and Baseline Characteristics for the Atrial Fibrillation Integrated Approach in Frail, Multimorbid and Polymedicated Older People (AFFIRMO) trial

Am Heart J

Proietti M, Lip GYH, Ainsworth J, Dan GA, Frost L, Graffigna G, Lucci D, Marin F, Potpara TS, Sanaullah A, Tokmakova M, Johnsen SP, Maggioni AP, AFFIRMO Study Investigators and Consortium

doi: 10.1016/j.ahj.2026.107356

Atrial Fibrillation

Atrial fibrillation recurrence and outcomes in patients with hypertrophic cardiomyopathy: Insights from a nationwide real-world cohort

Heart Rhythm

Aglan A, Fath AR, Silver JS, Harnish P, Hook B, Maron MS, Rowin EJ

doi: 10.1016/j.hrthm.2026.03.1906

Atrial FibrillationThrombosis and Stroke

Long-Term Outcomes Following Left Atrial Appendage Occlusion in Medicare Beneficiaries: Outcomes From the National Cardiovascular Data Registry

J Am Heart Assoc

Higgins AY, Zimmerman S, Wang Y, Friedman DJ, Faridi KF, Price MJ, Reddy VY, Holmes DR Jr, Curtis JP, Freeman JV

doi: 10.1161/JAHA.124.039780

Atrial Fibrillation

Left atrial appendage occlusion versus NOACs in patients with atrial fibrillation: Rationale and design of the CATALYST Trial

Am Heart J

Reddy VY, Hylek E, Camm AJ, Halperin JL, Diener HC, Thaler D, Schmidt B, Hara H, Huisman MV, Price MJ, Lakkireddy D, Gage R, Zhao H, Jensen TP, Quintana M, Windecker S

doi: 10.1016/j.ahj.2026.107367

Atrial FibrillationThrombosis and Stroke

Left Atrial Appendage Closure versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Long-Term Outcomes from Four Randomized Trials

Heart Rhythm

Kaisaier W, Xu Z, Guo L, Dong Y, Chen Y, Lip GYH, Zhu W

doi: 10.1016/j.hrthm.2025.07.051

Atrial FibrillationHeart Failure

Long-Term Effects of Catheter Ablation vs Medical Therapy in Patients with Atrial Fibrillation and Heart Failure: A Reconstructed Individual Patient Data Meta-Analysis

Heart Rhythm

Itaya ED, Aranha F, Barbosa LM, Silva Sanchez GJ, Ternes CMP, d'Avila A

doi: 10.1016/j.hrthm.2026.05.006

Atrial Fibrillation

Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuation

Cardiovasc Diabetol

Meulendijks ER, Fabrizi B, Bruns S, Eringa EC, Hoebe R, van den Boogert T, Wesselink R, Al-Shama RFM, de Vries TAC, Ernault AC, Niessen HWM, van Boven WJP, Driessen AHG, Zbairi I, Zappala P, Dey D, Isgum I, Planken RN, Krul SPJ, de Groot JR

doi: 10.1186/s12933-025-02985-1

Atrial FibrillationHeart Failure

External Validation of the REACT-HF Score for Predicting Heart Failure in Patients With Atrial Fibrillation

J Am Heart Assoc

Moschovitis G, Rigamonti E, Wiencierz A, Coslovsky M, Blum S, De Perna ML, Mayer-Melchiorre P, Vassalli G, Pedrazzini G, Healey JS, Reichlin T, Rodondi N, Müller A, Beer JH, Conte G, Stuber M, Schwenkglenks M, Mahfoud F, Sticherling C, Conen D, Osswald S, Kühne M, Krisai P, Swiss‐AF and BEAT‐AF Investigators

doi: 10.1161/JAHA.125.043058

Related content

Atrial Fibrillation Progression in Patients with Device-Detected Subclinical Atrial Fibrillation: Insights from the ARTESiA Trial

Integrated Care Management for Older Multimorbid Patients with Atrial Fibrillation: Rationale, Design and Baseline Characteristics for the Atrial Fibrillation Integrated Approach in Frail, Multimorbid and Polymedicated Older People (AFFIRMO) trial

Atrial fibrillation recurrence and outcomes in patients with hypertrophic cardiomyopathy: Insights from a nationwide real-world cohort

Long-Term Outcomes Following Left Atrial Appendage Occlusion in Medicare Beneficiaries: Outcomes From the National Cardiovascular Data Registry

Left atrial appendage occlusion versus NOACs in patients with atrial fibrillation: Rationale and design of the CATALYST Trial

Left Atrial Appendage Closure versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Long-Term Outcomes from Four Randomized Trials

Long-Term Effects of Catheter Ablation vs Medical Therapy in Patients with Atrial Fibrillation and Heart Failure: A Reconstructed Individual Patient Data Meta-Analysis

Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuation

External Validation of the REACT-HF Score for Predicting Heart Failure in Patients With Atrial Fibrillation